Health ❯Medicine ❯Pharmacology

Diabetes

Semaglutide GLP-1 Receptor Agonists Metformin Type 2 Diabetes GLP-1 Agonists Tirzepatide GLP-1 Medications

Metformin Use Tied to Lower Copper and Iron, Higher Zinc in Human Study

Researchers call for controlled trials to determine whether these metal shifts underlie the drug’s broader benefits.

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

Metformin Requires Hypothalamic Rap1 Inactivation to Lower Blood Sugar

GLP-1 Weight-Loss Injections Show Hormonal and Neuroprotective Benefits

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Ozempic May Lower Alzheimer's Risk in Type 2 Diabetics, Study Finds

Diabetes Drug Metformin Shows Promise in Slowing Brain Aging